Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis-Reference-Cited by-同舟云学术

Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis

Published:2023-03 Issue:2 Volume:22 Page:275-281
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Caley L.R.^ORCID,Zagoya C.,Duckstein F.,White H.,Shimmin D.,Jones A.M.^ORCID,Barrett J.^ORCID,Whitehouse J.L.^ORCID,Floto R.A.,Mainz J.G.,Peckham D.G.^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference37 articles.

1. Cystic fibrosis;Elborn;Lancet,2016

2. Cystic Fibrosis Trust. UK cystic fibrosis registry: 2020 annual data report London 2021 [Available from: https://www.cysticfibrosis.org.uk/sites/default/files/2021-12/CF_Annual%20Report%202020_V8.pdf.

3. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis;Derichs;Eur Respir Rev,2013

4. Cystic fibrosis: nutritional consequences and management;Dodge;Best Pract Res Clin Gastroenterol,2006

5. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders;Hayee;United Eur Gastroenterol J,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-cultural adaptation and validation of the CFAbd-Score for gastrointestinal symptoms in patients with cystic fibrosis;Jornal de Pediatria;2024-08

2. Scoring Abdominal Symptoms in People with Cystic Fibrosis;Journal of Clinical Medicine;2024-03-13

3. Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire;Frontiers in Pharmacology;2023-10-25

4. Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire;2023-08-02

5. Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD);Scientific Reports;2023-05-27